Detailseite
Projekt Druckansicht

Purinerge T-Zellregulation und post-traumatische Immunsuppression

Antragstellerin Dr. Carola Ledderose
Fachliche Zuordnung Orthopädie, Unfallchirurgie, rekonstruktive Chirurgie
Anästhesiologie
Immunologie
Förderung Förderung von 2013 bis 2015
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 240036772
 
Erstellungsjahr 2015

Zusammenfassung der Projektergebnisse

Sepsis is a leading cause of death in intensive care patients and a common complication in patients suffering from severe trauma or burn injuries. T cells play a central role in the regulation of the immune response. In patients with sepsis, T cell function is suppressed and renders the organism susceptible to hospital-acquired secondary infection; however, the pathogenic mechanisms leading to T cell suppression are not well understood. The overall aim of this project has been to explore the mechanisms that impair T cell function in sepsis. Specifically, I focused on the recently discovered purinergic signaling system that is known to regulate T cell activation under normal physiological conditions. Healthy T cells respond to the stimulation of their T cell receptors with the release of adenosine triphosphate (ATP) into the extracellular space. Following its release, ATP stimulates purinergic receptors expressed on the surface of T cells. This feedback is essential for effective functional T cell responses. Investigating the purinergic mechanisms that regulate T cell function under normal conditions, I found that mitochondria play a central role by providing the ATP that fuels this purinergic feedback process. T cell stimulation triggers ATP formation by mitochondria that accumulate at the immune synapse, the contact site between T cells and antigen-presenting cells. Using a novel fluorescence-based live-cell imaging method, I could demonstrate that ATP is released into the synaptic cleft where it stimulates P2X receptors. This promotes cellular calcium influx that up-regulates and perpetuates mitochondrial activity until the T cell response is completed. Interestingly, I discovered that not only stimulated T cells utilize this mechanism. Instead, I found a similar mechanism in unstimulated resting T cells. It keeps T cells alert and enables them to seek and recognize antigens and to quickly mount an appropriate functional response. Importantly, my studies revealed that this standby purinergic signaling system of unstimulated T cells is impaired in patients with sepsis, rendering these patients incapable of mounting adequate functional immune responses to infections. In conclusion, I was able to define a new mechanism that is responsible for T cell suppression in sepsis, suggesting novel therapeutic strategies targeting mitochondrial and purinergic dysfunction to improve T cell function and outcome in sepsis.

Projektbezogene Publikationen (Auswahl)

 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung